GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Total Liabilities

Sphere Medical Holding (LSE:SPHR) Total Liabilities : £0.76 Mil (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Total Liabilities?

Sphere Medical Holding's Total Liabilities for the quarter that ended in Dec. 2016 was £0.76 Mil.

Sphere Medical Holding's quarterly Total Liabilities declined from Dec. 2015 (£0.93 Mil) to Jun. 2016 (£0.82 Mil) and declined from Jun. 2016 (£0.82 Mil) to Dec. 2016 (£0.76 Mil).

Sphere Medical Holding's annual Total Liabilities increased from Dec. 2014 (£0.64 Mil) to Dec. 2015 (£0.93 Mil) but then declined from Dec. 2015 (£0.93 Mil) to Dec. 2016 (£0.76 Mil).


Sphere Medical Holding Total Liabilities Historical Data

The historical data trend for Sphere Medical Holding's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Total Liabilities Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 1.02 0.88 0.64 0.93 0.76

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.64 0.81 0.93 0.82 0.76

Sphere Medical Holding Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sphere Medical Holding's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.757+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.76

Total Liabilities=Total Assets (A: Dec. 2016 )-Total Equity (A: Dec. 2016 )
=6.966-6.209
=0.76

Sphere Medical Holding's Total Liabilities for the quarter that ended in Dec. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.757+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.76

Total Liabilities=Total Assets (Q: Dec. 2016 )-Total Equity (Q: Dec. 2016 )
=6.966-6.209
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.